Bayer Schering Expects Thailand To Be Leading Medical Hub
This article was originally published in PharmAsia News
Executive Summary
Bayer Schering Pharma Thailand expects the country to become a leading medical hub and its health care market to grow beyond its current $2.7 billion estimated value. Uwe Dalichow, country division head of the firm, said it expects its Thai business to grow with the market or even exceed the market average. He said he did not expect the pharmaceutical market in Thailand to be affected by challenges facing the rest of the industry and expected the market to grow by 13.1 percent 2012. (Click here for more